Childhood vaccination schedules look like administrative convenience. Each date reflects a compromise between three constraints that pull in different directions.
Borrowed antibodies fade on a timetable
Antibodies cross the placenta during late pregnancy, so a newborn arrives with protection reflecting the mother's own immune history.
These decline over the first months of life, and while present they can bind vaccine antigen and blunt the infant's own response to it.
Vaccinating too early therefore risks a weaker response, while waiting too long leaves a window in which borrowed protection has gone and none has replaced it.
The infant immune system matures unevenly
Responses to protein-based vaccines develop early, which is why several are given in the first months of life with good effect.
Responses to the sugar coatings of certain bacteria develop much later, so plain versions of those vaccines work poorly in infants.
Linking the sugar to a carrier protein recruits the pathway that does work at that age, which is what allowed those diseases to be addressed in infancy at all.
Risk is concentrated at particular ages
Several diseases are most dangerous in the first months, so protection is needed before the age at which severe cases cluster.
Whooping cough is the clearest example, since severe infant disease occurs before a course of infant doses could be completed.
Vaccinating during pregnancy addresses this by raising the antibodies transferred across the placenta, using the same maternal transfer that otherwise interferes with timing.
Repeated doses are doing distinct jobs
An initial series establishes a response, and later doses reinforce it, generating higher-quality antibodies and a larger population of memory cells.
Spacing between doses matters because the immune system needs time to complete the refinement that follows each exposure.
Boosters are scheduled at points where protection is known to wane or where exposure risk rises, such as school entry or adolescence, rather than at fixed intervals.
This is also why a delayed dose is generally resumed rather than restarted, since the earlier exposure left memory cells that a later dose can build on.
Schedules differ between countries
National schedules vary because disease prevalence, healthcare delivery and the ages at which children reliably attend clinics all differ.
A country where a disease is endemic may vaccinate earlier than one where it is rare, since the balance of risks is not the same.
Schedules also change as evidence accumulates, so decisions for any individual child belong with a doctor working from current national guidance.